Gen-Qiang Chen | Organic Chemistry | Best Researcher Award

Assoc. Prof. Dr. Gen-Qiang Chen | Organic Chemistry | Best Researcher Award

Associate Professor from Southern University of Science and Technology, China

Gen-Qiang Chen is a distinguished researcher and Professor at the Shenzhen Grubbs Institute, Southern University of Science and Technology. Renowned for his expertise in asymmetric catalysis, ligand design, and total synthesis of complex molecules, he has made substantial contributions to both fundamental research and industrial applications. His work has been published extensively in prestigious journals, including Nature Chemistry, Nature Communications, Journal of the American Chemical Society, Angewandte Chemie, and Science Advances. Chen’s research achievements have directly contributed to significant industrial advancements, such as the asymmetric synthesis of Sacubitril, a drug for heart failure treatment, which has led to the production of over 20 tons of intermediates and generated approximately 40 million yuan in industrial output. Recognized nationally, he has received competitive grants, awards, and honors, including the Guangdong Outstanding Youth Fund and the Shenzhen Natural Science First Prize. His work has been highlighted by the National Natural Science Foundation of China and featured by international research platforms like Synfacts. Chen’s balanced approach, integrating rigorous academic inquiry with practical, scalable applications, positions him as a leader in modern organic chemistry. He is actively engaged in reviewing for top journals, contributing to the scientific community’s advancement and maintaining high research standards.

Professional Profile

Education

Gen-Qiang Chen’s academic journey reflects a continuous pursuit of excellence in organic chemistry. He earned his Bachelor’s degree from Lanzhou University, one of China’s most respected institutions, where he developed a strong foundation in chemical sciences. Driven by a passion for advanced research, he pursued a PhD at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, completing his doctorate in 2012. His doctoral work focused on the development of new catalytic systems and the synthesis of bioactive molecules, setting the stage for his future research trajectory. Following his PhD, Chen undertook postdoctoral research at the prestigious California Institute of Technology (Caltech) in the United States. There, he worked under the mentorship of renowned chemists, expanding his expertise in asymmetric catalysis and gaining exposure to cutting-edge research methodologies and international collaboration. This blend of top-tier Chinese and international education provided Chen with a robust theoretical and experimental foundation, allowing him to bridge Eastern and Western research traditions. His educational path has not only equipped him with deep technical knowledge but also shaped his scientific perspective, enabling him to tackle complex research problems with innovative solutions and to mentor the next generation of scientists.

Professional Experience

Gen-Qiang Chen currently holds a professorship at the Shenzhen Grubbs Institute, Southern University of Science and Technology, where he leads a dynamic research group focused on asymmetric catalysis, ligand design, and total synthesis. Prior to this role, Chen gained valuable international experience during his postdoctoral work at Caltech, where he honed his skills in advanced catalytic methodologies and expanded his professional network. Upon returning to China, Chen took on faculty positions that allowed him to establish his independent research program, attracting competitive funding and assembling a talented team of researchers and students. Over the years, Chen has built strong collaborations with both academic and industrial partners, integrating fundamental research with real-world applications. His group has successfully designed novel chiral ligands, such as O-SDP, which have been adopted in industrial settings for the synthesis of important pharmaceuticals. Chen is also deeply involved in academic service, acting as a reviewer for leading journals and contributing to the organization of scientific conferences and workshops. His professional experience reflects a well-rounded combination of academic leadership, international collaboration, industrial engagement, and community service, marking him as an influential figure in the field of organic chemistry.

Research Interests

Gen-Qiang Chen’s research interests center on the design and development of new catalytic systems, particularly in asymmetric catalysis, which enables the selective production of chiral molecules. His work focuses on creating novel chiral ligands and catalysts that can surpass existing commercial systems in terms of efficiency, selectivity, and scalability. A major area of interest is the application of these catalysts in complex molecule synthesis, including the total synthesis of natural products and pharmaceuticals such as prostaglandins and Sacubitril. Chen is also keenly interested in understanding catalytic mechanisms at a fundamental level, using both experimental and computational tools to uncover the principles driving selectivity and reactivity. His research bridges the gap between fundamental chemistry and industrial application, ensuring that discoveries in the lab can be translated into real-world solutions. Additionally, Chen explores the development of highly selective catalysts for challenging transformations, such as asymmetric hydroformylation, which has broad implications for fine chemical production and material science. His work contributes to the advancement of green chemistry by aiming for more sustainable, efficient, and cost-effective processes, aligning with global efforts to reduce waste and improve chemical manufacturing practices.

Research Skills

Gen-Qiang Chen possesses a comprehensive set of research skills that span synthetic organic chemistry, asymmetric catalysis, ligand design, and mechanistic studies. He is highly skilled in designing and synthesizing chiral ligands and catalysts, demonstrating expertise in optimizing reaction conditions to achieve high selectivity and efficiency. Chen is adept at conducting total synthesis projects, including multi-step syntheses of complex natural products and pharmaceuticals, requiring advanced planning, problem-solving, and analytical techniques. He is proficient in using modern spectroscopic and chromatographic methods, such as NMR, HPLC, and mass spectrometry, to characterize reaction intermediates and products with precision. Additionally, Chen integrates computational chemistry approaches to investigate catalytic mechanisms, allowing his team to understand the molecular-level details that drive reactivity and selectivity. He has strong project management skills, overseeing multiple research projects simultaneously and guiding a team of graduate students and postdoctoral researchers. Chen’s ability to translate laboratory discoveries into industrial applications demonstrates his practical know-how and innovation. His experience in drafting patents and publishing high-impact research further reflects his skill in communicating scientific advances to both academic and industrial audiences, making him a versatile and impactful researcher.

Awards and Honors

Gen-Qiang Chen has received numerous prestigious awards and honors in recognition of his outstanding contributions to organic chemistry and catalysis research. Notably, he has been awarded the Guangdong Outstanding Youth Fund, a highly competitive grant that supports exceptional young scientists in advancing innovative research projects. He has also received the Shenzhen Natural Science First Prize, which acknowledges his groundbreaking work in developing chiral ligands and asymmetric catalytic methods with significant industrial applications. Chen’s research achievements have been repeatedly highlighted by the National Natural Science Foundation of China, underscoring his national prominence. Internationally, his work has been featured multiple times by Synfacts and Organic Chemistry Highlights, reflecting the global relevance and impact of his research. Additionally, Chen holds several patents for novel catalytic systems, further demonstrating the practical significance of his innovations. His role as a frequent reviewer for leading international journals and his participation in high-profile conferences and workshops attest to his strong standing in the scientific community. These recognitions not only celebrate his past achievements but also signal his potential to continue driving innovation and excellence in the field of asymmetric catalysis.

Conclusion

In conclusion, Gen-Qiang Chen exemplifies the qualities of a leading researcher in modern organic chemistry, combining deep scientific insight with practical innovation. His prolific publication record, cutting-edge catalytic systems, and impactful industrial collaborations highlight his ability to translate fundamental discoveries into real-world applications. Chen’s commitment to excellence is evident not only in his research output but also in his mentorship of young scientists, his service to the academic community, and his contribution to advancing chemical manufacturing processes. Recognized nationally and internationally, his achievements have positioned him as a rising star in the field, with the potential to influence the direction of asymmetric catalysis and ligand design for years to come. Chen’s balanced focus on both fundamental science and industrial relevance aligns with global priorities for sustainable and efficient chemical production. As he continues to expand his research portfolio and build international collaborations, his work will undoubtedly play a central role in shaping the future of organic synthesis. Gen-Qiang Chen’s exceptional track record and ongoing innovation make him a highly deserving candidate for the Best Researcher Award, reflecting his significant contributions to science and society.

Publications Top Notes

  • Title: Nano‐Scale Anti‐Cancer Drug Delivery by a Zn‐Based Metal Organic Framework Carrier
    Authors: P. Das, G. Chakraborty, J. Kaur, S.K. Mandal
    Journal: Small, 2408810
    Year: 2025

  • Title: Decoding Dual‐Functionality in N‐doped Defective Carbon: Unveiling Active Sites for Bifunctional Oxygen Electrocatalysis
    Authors: S. Bhardwaj, A. Pathak, S.K. Das, P. Das, R. Thapa, R.S. Dey
    Journal: Small, 2411035
    Year: 2025

  • Title: Synthesis of Doped g‐C₃N₄ Photonic Crystals for Enhanced Light‐Driven Hydrogen Production from Catalytic Water‐Splitting
    Authors: S.Y. Djoko T., S. Kwon, P. Das, V. Weigelt, W. Tahir, B. Radhakrishnan, …
    Journal: Advanced Energy and Sustainability Research 5 (12), 2400181
    Year: 2024

  • Title: Two-Dimensional Covalent Organic Frameworks: Structural Insights across Different Length Scales and Their Impact on Photocatalytic Efficiency
    Authors: I.E. Khalil, P. Das, A. Thomas
    Journal: Accounts of Chemical Research 57 (21), 3138–3150
    Year: 2024
    Citations: 9

  • Title: Hierarchical Porous Covalent Organic Frameworks: The Influence of Additional Macropores on Photocatalytic Hydrogen Evolution and Hydrogen Peroxide Production
    Authors: I.E. Khalil, P. Das, H. Küçükkeçeci, V. Dippold, J. Rabeah, W. Tahir, …
    Journal: Chemistry of Materials 36 (17), 8330–8337
    Year: 2024
    Citations: 8

  • Title: The Effect of Pore Functionality in Multicomponent Covalent Organic Frameworks on Stable Long‐Term Photocatalytic H₂ Production
    Authors: P. Das, G. Chakraborty, J. Yang, J. Roeser, H. Küçükkeçeci, A.D. Nguyen, …
    Journal: Advanced Energy Materials, 2501193
    Year: 2024
    Citations: 1

  • Title: Heteropolyaromatic Covalent Organic Frameworks via One-Pot Multicomponent Reactions
    Authors: P. Das, G. Chakraborty, N. Friese, J. Roeser, C. Prinz, F. Emmerling, …
    Journal: Journal of the American Chemical Society 146 (25), 17131–17139
    Year: 2024
    Citations: 9

  • Title: Reversible Solvent Interactions with UiO-67 Metal–Organic Frameworks
    Authors: E.B. Isabella Goodenough, M.C. Boyanich, R.P. McDonnell, L. McDonnell, …
    Journal: The Journal of Chemical Physics 160 (4)
    Year: 2024
    Citations: 3

  • Title: Zeolitic MOFs Get a Facelift
    Authors: N.L. Rosi, P. Das
    Journal: Nature Synthesis 3 (1), 5–6
    Year: 2024
    Citations: 1

  • Title: Polyoxometalate (POM) Boosting the Light-Harvesting Ability of Graphitic Carbon Nitride for Efficient Photocatalytic Hydrogen Production
    Authors: E. Njoyim, A.D. Nguyen, J. Yang, H. Küçükkeçeci, E.M. Kutorglo, …
    Journal: Catalysis Science & Technology 14 (8), 2114–2129
    Year: 2024
    Citations: 3

 

 

Sophia Lunt | Chemistry | Best Researcher Award

Prof. Sophia Lunt | Chemistry | Best Researcher Award

Professor at Michigan State University, United States

Dr. Sophia Y. Lunt is a prominent researcher at Michigan State University, specializing in cancer research, metabolism, and luminescent therapeutics. Her work focuses on understanding the reprogrammed metabolism in cancer and other diseases to develop novel therapeutic strategies. With a strong academic and research background, Dr. Lunt has led an independent cancer research laboratory and contributed significantly to the scientific community through high-impact publications. She has secured funding from notable organizations such as NIH, NSF, and DoD, which has enabled her to lead groundbreaking research in cancer metabolism. Dr. Lunt is also passionate about education, promoting student engagement and inclusivity, and has received multiple teaching awards for her efforts. As a mentor, she has successfully guided postdoctoral fellows, graduate students, and undergraduates, helping shape the next generation of researchers.

Professional Profile

Education:

Dr. Sophia Y. Lunt’s academic journey began at Lebanon Valley College, where she graduated summa cum laude with a B.S. in Chemistry in 2005. She then pursued her Ph.D. in Chemistry at Princeton University, where her research focused on metabolomic investigations of drug action. After completing her doctorate in 2010, she worked as a DoD Visionary Postdoctoral Fellow at the Massachusetts Institute of Technology (MIT). During her postdoctoral tenure, she studied the impact of pyruvate kinase isoform expression on cancer cell metabolism and proliferation under the mentorship of Professor Matthew G. Vander Heiden. This extensive educational background provided Dr. Lunt with the expertise to build an innovative research program in cancer metabolism at Michigan State University, where she has been a faculty member since 2015.

Professional Experience:

Dr. Lunt’s professional journey is marked by significant academic and research leadership. After earning her Ph.D. and completing her postdoctoral research, Dr. Lunt joined Michigan State University (MSU) in 2015 as an Assistant Professor. She quickly ascended through the ranks, achieving tenure as an Associate Professor in 2021 and later as a Professor with Tenure in 2024. Throughout her tenure at MSU, she has been instrumental in developing a thriving cancer research laboratory, securing multiple research grants, and contributing to academic growth in the Biochemistry and Molecular Biology, as well as Chemical Engineering and Materials Science departments. In addition to her faculty roles, Dr. Lunt has served as an advisory board member at the Van Andel Institute’s Metabolism & Nutrition Program and as an editorial board member for Cancer & Metabolism. Her experience also extends to mentorship, as she has trained postdoctoral fellows, graduate students, and undergraduates in cancer research and metabolism.

Research Interests:

Dr. Lunt’s primary research interest lies at the intersection of cancer, metabolism, and luminescent therapeutics. Her work investigates how metabolic alterations in cancer cells contribute to disease progression and resistance to therapies. Specifically, she focuses on understanding the reprogramming of cellular metabolism in cancer and how these changes can be exploited to develop targeted therapies. By studying the role of pyruvate kinase isoform expression and other metabolic pathways in cancer cell metabolism, Dr. Lunt aims to uncover novel therapeutic strategies for treating cancer. Additionally, her research includes developing luminescent-based therapeutics for better-targeted treatments in cancer. Her work also extends to broader metabolic diseases, with a focus on how metabolic reprogramming can influence disease mechanisms and therapy outcomes.

Research Skills:

Dr. Lunt possesses a diverse set of research skills that span across cancer biology, biochemistry, and metabolic diseases. Her expertise includes cell metabolism analysis, metabolomics, and the use of luminescent therapeutics for targeted drug delivery. She has mastered techniques in molecular biology, bioenergetics, and the study of pyruvate kinase isoform expression in cancer. Dr. Lunt is proficient in metabolomic analysis, cell culture, and animal model systems, which allow her to explore the metabolic alterations that drive disease progression. Her ability to secure and manage multiple research grants reflects her proficiency in writing competitive research proposals and leading large-scale research projects. Additionally, Dr. Lunt’s mentorship skills are evident in her successful training of numerous students and fellows who have gone on to make significant contributions in cancer research.

Awards and Honors:

Dr. Sophia Y. Lunt has received numerous accolades throughout her career, reflecting her excellence in research and teaching. Among her most prestigious honors is the 2022-23 MSU NatSci Teacher-Scholar Award, recognizing her outstanding contributions to teaching and mentorship. Additionally, she was awarded the 2022 Biochemistry & Molecular Biology Teaching Award for her efforts in fostering an inclusive learning environment. Dr. Lunt’s research excellence has also been recognized through competitive grants such as the NIH NCI R01 and the NSF CAREER Award. She has received several awards to support her cancer research, including the DoD Breast Cancer Research Program Breakthrough Award and the METAvivor Early Career Investigator Award. These honors, along with her extensive publication record in top-tier journals like Nature and Cancer Cell, underscore her impact in the scientific community.

Conclusion:

Dr. Sophia Y. Lunt is a leading researcher and educator with an impressive track record in cancer research, metabolism, and luminescent therapeutics. Her innovative research in metabolic reprogramming of cancer cells is making significant strides in developing novel therapeutic approaches. Through her independent research program, she has demonstrated exceptional leadership and mentorship, guiding numerous students and postdoctoral fellows to success. Dr. Lunt’s research, teaching, and outreach are highly regarded in the academic community, as evidenced by her substantial publication record, competitive grant funding, and numerous awards. Her commitment to advancing scientific knowledge, coupled with her dedication to mentoring the next generation of researchers, makes her an exemplary candidate for the Research for Best Researcher Award.

Publication Top Notes

  • Title: Aerobic glycolysis: meeting the metabolic requirements of cell proliferation
    • Authors: SY Lunt, MG Vander Heiden
    • Journal: Annual Review of Cell and Developmental Biology
    • Volume: 27 (1), 441-464
    • Citations: 3378
    • Year: 2011
  • Title: Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
    • Authors: D Anastasiou, Y Yu, WJ Israelsen, JK Jiang, MB Boxer, BS Hong, …
    • Journal: Nature Chemical Biology
    • Volume: 8 (10), 839-847
    • Citations: 820
    • Year: 2012
  • Title: A roadmap for interpreting 13C metabolite labeling patterns from cells
    • Authors: JM Buescher, MR Antoniewicz, LG Boros, SC Burgess, H Brunengraber, …
    • Journal: Current Opinion in Biotechnology
    • Volume: 34, 189-201
    • Citations: 660
    • Year: 2015
  • Title: Fatty acid carbon is essential for dNTP synthesis in endothelial cells
    • Authors: S Schoors, U Bruning, R Missiaen, KCS Queiroz, G Borgers, I Elia, …
    • Journal: Nature
    • Volume: 520 (7546), 192-197
    • Citations: 619
    • Year: 2015
  • Title: Metabolic pathway alterations that support cell proliferation
    • Authors: MG Vander Heiden, SY Lunt, TL Dayton, BP Fiske, WJ Israelsen, …
    • Journal: Cold Spring Harbor Symposia on Quantitative Biology
    • Volume: 76, 325-334
    • Citations: 343
    • Year: 2011
  • Title: Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation
    • Authors: SY Lunt, V Muralidhar, AM Hosios, WJ Israelsen, DY Gui, L Newhouse, …
    • Journal: Molecular Cell
    • Volume: 57 (1), 95-107
    • Citations: 261
    • Year: 2015
  • Title: Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism
    • Authors: PJP Aspuria, SY Lunt, L Väremo, L Vergnes, M Gozo, JA Beach, …
    • Journal: Cancer & Metabolism
    • Volume: 2, 1-15
    • Citations: 175
    • Year: 2014
  • Title: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
    • Authors: M Rossi, P Altea-Manzano, M Demicco, G Doglioni, L Bornes, M Fukano, …
    • Journal: Nature
    • Volume: 605 (7911), 747-753
    • Citations: 153
    • Year: 2022
  • Title: A domino effect in antifolate drug action in Escherichia coli
    • Authors: YK Kwon, W Lu, E Melamud, N Khanam, A Bognar, JD Rabinowitz
    • Journal: Nature Chemical Biology
    • Volume: 4 (10), 602-608
    • Citations: 120
    • Year: 2008
  • Title: The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function
    • Authors: M Wenes, A Jaccard, T Wyss, N Maldonado-Pérez, ST Teoh, A Lepez, …
    • Journal: Cell Metabolism
    • Volume: 34 (5), 731-746.e9
    • Citations: 114
    • Year: 2022

 

Madhukar Hemamalini | Organic Synthesis | Best Researcher Award

Dr. Madhukar Hemamalini | Organic Synthesis | Best Researcher Award

Assistant Professor at Mother Teresa Women’s University, India.

Dr. M. Hemamalini is an Assistant Professor in the Department of Chemistry at Mother Teresa Women’s University, Kodaikanal, with over five and a half years of research experience and 12 years of teaching expertise. She has published 246 international research papers and has guided multiple Ph.D., M.Phil., and M.Sc. students, reflecting her commitment to education and research. Her expertise lies in X-ray crystallography, bioorganic and bioinorganic chemistry, and macromolecular studies, with a focus on protein-ligand interactions and supramolecular frameworks. Dr. Hemamalini’s technical skills include extensive experience with various spectroscopic instruments and molecular biology techniques. She has earned multiple awards, including the Best Researcher Award from Mother Teresa Women’s University and the Research Excellence Award from the Institute of Scholars. With post-doctoral experience from Singapore and Malaysia, Dr. Hemamalini continues to make significant contributions to chemical research, mentoring, and advancing scientific understanding in her field.

Profile

Education

Dr. M. Hemamalini holds a Ph.D. in Chemistry from Bharathidasan University, India, awarded in October 2006. Her doctoral research focused on chemical crystallography, particularly exploring crystal engineering and supramolecular designs under the guidance of Prof. P. Thomas Muthiah. Prior to her Ph.D., she completed her Master of Science (M.Sc.) in Chemistry from Bharathidasan University in August 2000, where she gained in-depth knowledge of various chemical principles and research methodologies. Dr. Hemamalini also earned a Bachelor of Science (B.Sc.) in Chemistry from Holy Cross College, affiliated with Bharathidasan University, in August 1998. Throughout her academic journey, she developed a strong foundation in both theoretical and applied chemistry, which laid the groundwork for her future research endeavors. Her educational background, coupled with her specialized training in crystallography and molecular chemistry, has enabled her to excel in both academia and research, contributing to her success as a scholar and educator.

Professional Experience

Dr. M. Hemamalini is an accomplished Assistant Professor in the Department of Chemistry at Mother Teresa Women’s University, Kodaikanal, where she has been teaching since March 2015. With 12 years of teaching experience, she has mentored numerous students, including 4 Ph.D. scholars, 12 M.Phil students, and 67 M.Sc. graduates. Prior to this, she served as an Associate Professor at Veltech Multitech Engineering College, Chennai, and as an Assistant Professor at R.M.K. Engineering College, Kummidipoondi. Her research experience is equally impressive, with post-doctoral fellowships in crystallography at Universiti Sains Malaysia and structural biology at the Institute of Molecular and Cell Biology (IMCB), Singapore. Dr. Hemamalini’s research expertise lies in X-ray crystallography, bioorganic and bioinorganic chemistry, and protein-ligand interactions. She has published over 246 international papers, highlighting her significant contributions to her field. Her academic and research roles have earned her several prestigious awards, including the Best Researcher Award.

Research Interest

Dr. M. Hemamalini’s research interests are centered around the structural and functional analysis of macromolecules, particularly through the application of X-ray crystallography. She focuses on understanding protein-ligand interactions, nucleic acids, and the biochemical processes involved in macromolecular chemistry. Her work extends to synthesizing bioorganic and bioinorganic molecules, using advanced spectroscopic techniques to analyze their structure and interactions. Dr. Hemamalini is particularly interested in applying her chemical knowledge to study drug-receptor interactions and biomolecular recognition, which has implications for pharmaceutical and biomedical research. She also explores supramolecular chemistry and crystal engineering, investigating hydrogen bonding motifs and non-covalent interactions to design new supramolecular frameworks. Her postdoctoral experience in synthesizing pharmaceutical solids and metal coordination complexes further contributes to her expertise in the field, with a strong emphasis on structural biology and the synthesis of bioorganic derivatives for therapeutic applications.

Research Skills

Dr. M. Hemamalini possesses a wide range of research skills, particularly in the field of X-ray crystallography, where she excels in data collection, structure solution, and refinement using advanced software like SHELXS, CCP4 Suite, and COOT. She has extensive expertise in cloning, protein expression, and purification, with hands-on experience in techniques such as affinity chromatography, gel filtration, and crystallization. Dr. Hemamalini is proficient in the synthesis of bioorganic and bioinorganic molecules, with a focus on supramolecular motifs and metal complexes, contributing to drug-receptor interaction studies. Her knowledge extends to spectroscopic techniques, including IR, NMR, UV, and HPLC, essential for structural analysis and compound characterization. Furthermore, her skills in molecular biology include transformation, protein assays, and diffraction studies, enhancing her ability to work on complex biochemical interactions. Her expertise is supported by post-doctoral work and numerous publications, establishing her as a skilled researcher in both experimental and computational chemistry.

Award and Recognition

Dr. M. Hemamalini has received numerous prestigious awards and recognitions for her contributions to the field of chemistry. She was honored with the SERB-International Research Experience Award (2022-2023) by DST, India, recognizing her research excellence on a global scale. In 2020, she received the Research Excellence Award from the Institute of Scholars, Bangalore, further acknowledging her innovative contributions. Dr. Hemamalini was also awarded Best Poster Award for her work on Nickel (II) complexes at an international seminar in 2019. Her significant achievements in research led to her being recognized as the Best Researcher by Mother Teresa Women’s University (2018-2019) and Grabs Educational Charitable Trust (2019). Additionally, she earned the Senior Research Fellow Award from the Council of Scientific and Industrial Research (CSIR) during 2004-2006, cementing her reputation as an exceptional researcher early in her career.

Conclusion

Dr. M. Hemamalini is a highly qualified candidate for the Research for Best Researcher Award. Her extensive research experience, substantial publication record, significant contributions to teaching and mentorship, and numerous awards make her a strong contender. Addressing areas for improvement, such as fostering interdisciplinary collaborations and enhancing the broader impact of her research, could further solidify her standing as a leading researcher. Overall, Dr. Hemamalini’s profile aligns well with the criteria for the award, reflecting both depth in her research area and a commitment to advancing scientific knowledge.

Publications Top Notes

  • Title: Insights into Oxidovanadium (3,4,5-Trimethoxyphenyl) Porphyrin: A Comprehensive Study of Synthesis, Crystal Structure, Hirshfeld Surface Analysis, and Computational Studies
    • Authors: Muzaddadi, I.U., Murugan, A., Hemamalini, M., Mandal, V.K., Ahmed, B.
    • Year: 2024
    • Citations: 1
  • Title: 2-(10-Bromoanthracen-9-yl)-N-phenylaniline
    • Authors: Saravanan, D., Ponraj, C., Khamrang, T., Hemamalini, M., Jerald Maria Antony, G.
    • Year: 2024
  • Title: DFT, Molecular Docking, Energy-Framework, In-Silico ADME Analysis of 2,6-Diamino-4-chloropyrimidine–succinic Acid (2/1)
    • Authors: Chakkarapani, N., Madhukar, H., Venkatachalam, R.
    • Year: 2024
  • Title: 10-Bromo-N,N-diphenylanthracen-9-amine
    • Authors: Sureshkumar, K., Khamrang, T., Hemamalini, M., Saravanan, D., Antony, G.J.M.
    • Year: 2024
  • Title: Shining Light on Chalcone Compounds: A Comprehensive Exploration Through Optical and Thermal Studies
    • Authors: Nehru, J., Subramani, S., Rosli, M.M., Venkatachalam, R., Madhukar, H.
    • Year: 2024
  • Title: Investigation of Oxidative Behaviour and Structural Insights of (3,4,5-Trimethoxyphenyl)Porphyrin Ni(II) Complex: Experimental and Theoretical Study
    • Authors: Muzaddadi, I.U., Murugan, A., Hemamalini, M., Hussain, M.F., Rajkumar, T.
    • Year: 2024
  • Title: In Silico and In Vitro Studies for the Identification of Small Molecular Inhibitors from Euphorbia Hirta Linn for Rheumatoid Arthritis: Targeting TNF-α-Mediated Inflammation
    • Authors: Velmurugan, Y., Natarajan, S.R., Chakkarapani, N., Madhukar, H., Venkatachalam, R.
    • Year: 2024
  • Title: A Novel Cadmium Metal-Organic Framework with Exceptional Nonlinear Optical Properties: Unveiling Anisotropic Charge Transport and Optical Limiting Behavior
    • Authors: Catherine Paul, A., Hemamalini, M., Mustaqim Rosli, M., Alwani Zainuri, D., Abdul Razak, I.
    • Year: 2024
  • Title: 4-Amino-3,5-dichloropyridinium 3-hydroxypicolinate Monohydrate
    • Authors: Ashokan, A., Nehru, J., Chakkarapani, N., Rajakannan, V., Hemamalini, M.
    • Year: 2023
  • Title: (2,4-Dichlorobenzylidene)[2-(1H-indol-3-yl)ethyl]-amine
    • Authors: Murugan, S., Paul, A.C., Khamrang, T., Rajakannan, V., Hemamalini, M.
    • Year: 2023